Tadashi Umemoto, PhDGeneral Manager, Research and Development at Luxna Biotech Co., Ltd.
Tadashi Umemoto is a General Manager of R&D at Luxna Biotech since 2018. Umemoto is managing R&D to develop the Luxna’s XNA incorporated Antisense Platform, or LuxiAP. Before joining Luxna Biotech, Umemoto has drug discovery experience in Takeda pharmaceuticals about nucleic acid therapeutics and peptide medicine. Umemoto received his Ph.D in nucleic acid chemistry from the University of Tokyo (supervised by prof. Wada) and his postdoctoral training at University of Southern Denmark (supervised by J. Wengel).